GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abionyx Pharma (FRA:609) » Definitions » 12-1 Month Momentum %

Abionyx Pharma (FRA:609) 12-1 Month Momentum % : -0.77% (As of Dec. 14, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Abionyx Pharma 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-12-14), Abionyx Pharma's 12-1 Month Momentum % is -0.77%.

The industry rank for Abionyx Pharma's 12-1 Month Momentum % or its related term are showing as below:

FRA:609's 12-1 Month Momentum % is ranked better than
57.92% of 1445 companies
in the Biotechnology industry
Industry Median: -13.2 vs FRA:609: -0.77

Competitive Comparison of Abionyx Pharma's 12-1 Month Momentum %

For the Biotechnology subindustry, Abionyx Pharma's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abionyx Pharma's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abionyx Pharma's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Abionyx Pharma's 12-1 Month Momentum % falls into.



Abionyx Pharma  (FRA:609) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abionyx Pharma  (FRA:609) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Abionyx Pharma 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Abionyx Pharma's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Abionyx Pharma Business Description

Traded in Other Exchanges
Address
33-43 Avenue Georges Pompidou-Bat D2, Balma, FRA, 31130
Abionyx Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. The biotech assets inherited from CERENIS Therapeutics constitute a portfolio of valuable programs for the treatment of cardiovascular diseases and associated metabolic diseases such as NAFLD and NASH as well as an HDL targeted drug delivery platform in oncology, more specifically in Immuno oncology and chemotherapy.

Abionyx Pharma Headlines

No Headlines